Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;25(3):255-260.
doi: 10.1097/MOT.0000000000000760.

The aging transplant population and immunobiology: any therapeutic implication?

Joanna Schaenman  1 , Deena Goldwater  2
Affiliations
Review

The aging transplant population and immunobiology: any therapeutic implication?

Joanna Schaenman et al. Curr Opin Organ Transplant. 2020 Jun.

Abstract

Purpose of review: The aim of this review is to describe the latest investigations into the immunobiology of aging and the potential impact on outcomes after mechanical circulatory support implantation and heart transplantation. This information is relevant given the growing numbers of older patients with heart failure undergoing evaluation for mechanical circulatory support device (MCSD) or heart transplantation.

Recent findings: A host of aging-associated aspects of immune dysfunction have been described in the general population including T-cell senescence, exhaustion, and terminal dedifferentiation, as well as impaired function of innate immune cells. Another important consequence of T-cell senescence is inflammation, which is known to have a strong relationship with both heart failure and frailty in older patients. Recent data on the association between T-cell and monocyte phenotypes as well as evaluation of gene expression and adverse outcomes after MCSD suggests the potential value of immunologic assessment of MCSD and heart transplant candidates and recipients. Measurement of physical frailty represents another avenue for patient evaluation that may complement immunologic assessment. Determination of immune dysfunction and frailty prior to transplantation may have implications for choice of induction and dosing of maintenance immunosuppression.

Summary: As the age of transplant and MCSD candidates and recipients continues to increase, it is important for providers to recognize the potential impact of aging-associated immune dysfunction and how it may influence candidate selection, postintervention monitoring, and adjustment of immunosuppression.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

References

    1. Butrous H, Hummel SL. Heart Failure in Older Adults. Can J Cardiol. 2016;32(9):1140–7. - PMC - PubMed
    1. Kim JH, Singh R, Pagani FD, Desai SS, Haglund NA, Dunlay SM, et al. Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes. J Card Fail. 2016;22(12):981–7. - PubMed
    1. Colvin M, Smith JM, Hadley N, Skeans M, Uccellini K, Goff R, et al. OPTN/SRTR 2018 Annual Data Report: Heart. American Journal of Transplantation. 2020;20(S1):340–426. - PubMed
    1. Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, et al. Eighth annual INTERMACS report_ Special focus on framing the impact of adverse events. Journal of Heart and Lung Transplantation. 2017;36(10):1080–6. - PubMed
    1. Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships. Ann Thorac Surg. 2019;107(2):341–53. - PubMed